CCDC86 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.657580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.262210E-01
Normal-vs-Stage2
7.420500E-02
Normal-vs-Stage3
7.059000E-01
Normal-vs-Stage4
1.125620E-01
Stage1-vs-Stage2
3.698200E-01
Stage1-vs-Stage3
2.566600E-01
Stage1-vs-Stage4
8.556200E-01
Stage2-vs-Stage3
1.446190E-01
Stage2-vs-Stage4
8.863700E-02
Stage3-vs-Stage4
1.717800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.552500E-04
Normal-vs-AfricanAmerican
5.208400E-02
Normal-vs-Asian
5.579200E-03
Caucasian-vs-AfricanAmerican
9.580600E-01
Caucasian-vs-Asian
1.214020E-01
AfricanAmerican-vs-Asian
4.115600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.566880E-04
Normal-vs-Female
1.255230E-01
Male-vs-Female
7.557000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.179600E-01
Normal-vs-Age(41-60Yrs)
3.89699999999715E-05
Normal-vs-Age(61-80Yrs)
1.767030E-01
Normal-vs-Age(81-100Yrs)
1.156230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.613600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.806800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.835400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.462850E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.830600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.662600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.990420E-01
Normal-vs-Daily Drinker
8.406200E-02
Normal-vs-Weekly Drinker
3.841800E-03
Normal-vs-Occasional Drinker
8.783300E-03
Normal-vs-Social Drinker
1.013570E-02
Non Drinker-vs-Daily Drinker
2.807600E-01
Non Drinker-vs-Weekly Drinker
1.148810E-01
Non Drinker-vs-Occasional Drinker
1.426790E-01
Non Drinker-vs-Social Drinker
3.250200E-01
Daily Drinker-vs-Weekly Drinker
2.984400E-01
Daily Drinker-vs-Occasional Drinker
3.430200E-01
Daily Drinker-vs-Social Drinker
7.827400E-01
Weekly Drinker-vs-Occasional Drinker
8.780800E-01
Weekly Drinker-vs-Social Drinker
2.559200E-01
Occasional Drinker-vs-Social Drinker
2.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.999400E-01
Normal-vs-Grade 2
7.460000E-01
Normal-vs-Grade 3
7.388800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.386000E-01
Grade 1-vs-Grade 3
4.875600E-01
Grade 1-vs-Grade 4
5.999400E-01
Grade 2-vs-Grade 3
7.805000E-01
Grade 2-vs-Grade 4
7.460000E-01
Grade 3-vs-Grade 4
7.388800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.798600E-03
Normal-vs-NonDiabetic
1.121770E-01
Diabetic-vs-NonDiabetic
6.064400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.435200E-03
Normal-vs-NoPancreatitis
2.647800E-04
Pancreatitis-vs-NoPancreatitis
8.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.032530E-04
Normal-vs-N1
8.771800E-02
N0-vs-N1
2.861800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.010100E-02
Normal-vs-TP53-NonMutant
9.681700E-03
TP53-Mutant-vs-TP53-NonMutant
9.838800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
